News - Business Finance

Filter

Current filters:

Business Finance

Popular Filters

1 to 25 of 46 results

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

31-07-2014

Sweden’s Meda says it has entered into a definitive agreement to acquire Rottapharm Madaus, an Italian…

Business FinanceItalyMedaMergers & AcquisitionsMergers and acquisitionsPharmaceuticalRottapharm MadausSwedenSweden

Dr Reddy’s achieves quarterly earnings growth of over 50%

Dr Reddy’s achieves quarterly earnings growth of over 50%

31-07-2014

Indian pharmaceutical company Dr Reddy’s has announced quarterly sales of 35.2 billion rupees.

Business FinanceDr Reddy's LaboratoriesFinancialFundamental analysisGenericsHealth Medical PharmaIndia

Receptos appoints Mary Szela and Richard Heyman to board of directors

Receptos appoints Mary Szela and Richard Heyman to board of directors

29-07-2014

Biopharmaceutical company Receptos has appointed Mary Szela and Richard Heyman to the board of directors.

BoardroomBusinessBusiness FinanceCorporations lawHealth Medical PharmaManagementPharmaceuticalReceptosUSA

Gilead beats forecasts as Sovaldi sales soar

Gilead beats forecasts as Sovaldi sales soar

24-07-2014

US anti-virals specialist biotech firm Gilead Sciences has reported surging second-quarter 2014 sales…

Anti-viralsBiotechnologyBusiness FinanceBusiness FinanceChemistryFinancialFixed dose combinationGilead SciencesSovaldiTenofovir

Charles Ramat and Paul Freiman named co-chief executive of Neurotrope

Charles Ramat and Paul Freiman named co-chief executive of Neurotrope

21-07-2014

US-based Neurotrope, developers of diagnostic and therapeutic technologies for the treatment of neurodegenerative…

BiotechnologyBoardroomBusiness FinanceCo-chiefDiagnostic and therapeutic technologiesNeurologicalNeurotropePermanent chief executiveSyntexUSA

New products drive 2nd-qtr growth for Johnson & Johnson

New products drive 2nd-qtr growth for Johnson & Johnson

15-07-2014

Global health care products giant Johnson & Johnson, the first pharma to report second-quarter 2014 financial…

Business FinanceFinancialJohnson & JohnsonMonoclonal antibodiesPharmaceuticalPrednisoneUSA

Anthera appoints Chuck Olson as president of Alkira

Anthera appoints Chuck Olson as president of Alkira

15-07-2014

US-based biopharma Anthera Pharmaceuticals has appointed Chuck Olson as president of its subsidiary Alkira…

Anthera PharmaceuticalsBoardroomBusiness FinanceBusiness FinanceGastro-intestinalsHealth Medical PharmaPancreasPharmaceuticalProduct manufacturingUSA

Merck Serono appoints Luciano Rossetti as Global Head of research and development

Merck Serono appoints Luciano Rossetti as Global Head of research and development

14-07-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has announced the appointment of Luciano Rossetti…

BoardroomBusiness FinanceGermanyLuciano RossettiMerckMerck KGaAMerck SeronoPharmaceuticalSenior vice president of late stage development

ScinoPharm chief exec Jo Shen to retire and be replaced by Yung-Fa Chen

ScinoPharm chief exec Jo Shen to retire and be replaced by Yung-Fa Chen

11-07-2014

Taiwan-based pharmaceutical company ScinoPharm (TWSE: 1789) says that its president and chief executive…

Asia-PacificBoardroomBusiness FinanceChenHealth Medical PharmaPharmaceuticalPharmaceutical industryPresident and chief executiveScinoPharm

$25 million milestone for Incyte on Japanese approval of Jakavi

$25 million milestone for Incyte on Japanese approval of Jakavi

08-07-2014

US biopharma company Incyte says it has earned a $25 million milestone payment from Swiss drug major…

BiotechnologyBusiness FinanceBusiness FinanceFinancialIncyteJakaviJapanMajorMedicineNovartisOncologyRegulationRuxolitinib

Vertex leaps on positive Ph III results with lumacaftor

Vertex leaps on positive Ph III results with lumacaftor

24-06-2014

US biotech firm Vertex Pharmaceuticals saw its share price rocket nearly 52% to $101.20 in extending…

BiotechnologyBusiness FinanceCystic fibrosisHealth Medical PharmaKalydecolumacaftorMedicinePhenolsRare diseasesRegulationResearchVertex Pharmaceuticals

Allergan rejects Valeant’s latest bid

Allergan rejects Valeant’s latest bid

24-06-2014

Botox maker Allergan has announced that its Board of Directors has unanimously determined that Valeant…

AllerganBusiness FinanceBusiness FinanceEconomicsFinanceMergers & AcquisitionsPharmaceuticalStock marketUSAValeant Pharmaceuticals

New treatments to boost hepatitis C market to $19.2 billion by 2016

New treatments to boost hepatitis C market to $19.2 billion by 2016

24-06-2014

The launch of interferon-free regimens is expected to boost the hepatitis C market from $2.9 billion…

Anti-viralsAntiviralsBusiness FinanceCytokinesDatamonitorGilead SciencesGlobalMajorMarkets & MarketingPharmaceuticalSovaldi

Australian biotech survey shows advanced manufacturing heading overseas

Australian biotech survey shows advanced manufacturing heading overseas

12-06-2014

The annual Australian Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced…

AustraliaBiotechnologyBusiness FinanceBusiness FinanceChief executiveFinancialHealthcare in IndiaInnovationPoliticsProduction

China’s API industry is leading world production says new report

China’s API industry is leading world production says new report

05-06-2014

China’s chemical drug preparation industry and active pharmaceutical ingredient (API) industry recorded…

BiotechnologyBusiness FinanceChinaProduction

Stada will continue to develop emerging markets as domestic growth drops

Stada will continue to develop emerging markets as domestic growth drops

05-06-2014

German generic and branded drugmaker Stada Arzneimittel’s executive board chairman, Hartmut Retzlaff,…

Business FinanceBusiness FinanceFinancialGenericsGermanyPharmaceuticalSTADA ArzneimittelSTADA Pharmaceuticals

arGEN-X and Shire sign long term collaboration deal worth $20 million

arGEN-X and Shire sign long term collaboration deal worth $20 million

04-06-2014

Belgium-based preclinical stage biotech firm arGEN-X has entered into a long-term strategic alliance…

arGEN-XBiotechnologyBusiness FinanceEuropeHuman antibody discovery technologiesResearchShireShire Pharmaceuticals

Allergan warns shareholders to take no action ahead of Valeant calling ‘special meeting’

Allergan warns shareholders to take no action ahead of Valeant calling ‘special meeting’

03-06-2014

Takeover target USA-based Allergan has responded to action taken by Canadian drugmaker Valeant Pharmaceuticals…

AllerganBusiness FinanceMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

1 to 25 of 46 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top